Related Experiment Video
Updated: Nov 26, 2025

09:49
Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
1.7K
Estradiol resolves pneumonia via ERβ in regulatory T cells
JCI Insight
|December 8, 2020
Summary
Estradiol (E2) enhances the resolution of pneumonia-induced acute lung injury (PNA-ALI) by boosting regulatory T cells (Tregs) via ERβ signaling. This suggests E2 as a potential therapy for PNA-ALI, particularly in males.
Area of Science:
- Immunology
- Endocrinology
- Pulmonology
Background:
- Pneumonia-induced acute lung injury (PNA-ALI) has high mortality, necessitating novel therapeutic targets beyond pathogen-focused treatments.
- Sex differences in PNA survival suggest a role for sex hormones, with males exhibiting higher mortality.
- Regulatory T cells (Tregs) are crucial for resolving lung injury, and their function may be modulated by estradiol (E2).
Purpose of the Study:
- To investigate the role of estradiol (E2) in sex-based differences in pneumonia resolution.
- To determine if E2 enhances Treg function and promotes PNA-ALI resolution.
- To elucidate the specific estrogen receptor (ER) pathway involved in E2's effects on Tregs.
Main Methods:
- Utilized a mouse model of severe pneumococcal pneumonia.
- Administered systemic E2 to male mice and evaluated PNA resolution.
- Depleted Tregs (Foxp3DTR mice) and performed adoptive transfer of E2-treated Tregs.
- Assessed Treg phenotype (Foxp3, CD25, GATA3 expression) and macrophage inflammatory responses.
- Investigated the roles of ERα and ERβ signaling.
Main Results:
- Female mice showed enhanced PNA resolution with less lung inflammation and more Tregs compared to males.
- E2 administration promoted PNA resolution in male mice, independent of bacterial clearance.
- E2 upregulated Treg markers (Foxp3, CD25, GATA3) via ERβ signaling.
- Therapeutic effects of E2 were abolished in Treg-depleted mice.
- Adoptive transfer of E2-treated Tregs rescued PNA-ALI, requiring Treg ERβ expression.
- E2/ERβ signaling in Tregs was essential for controlling macrophage proinflammatory responses.
Conclusions:
- Estradiol (E2) promotes the resolution of pneumonia-induced acute lung injury (PNA-ALI) by enhancing regulatory T cell (Treg) function.
- The therapeutic effects of E2 are mediated through the ERβ receptor on Tregs.
- E2/ERβ signaling in Tregs is critical for resolving lung inflammation and controlling macrophage responses in PNA-ALI.
- E2 represents a potential therapeutic strategy for PNA-ALI, particularly for improving outcomes in males.
Related Concept Videos
Pneumonia II: Pathophysiology
2.0K
The pathophysiology of pneumonia involves the following steps:
2.0K
Regulation of the Unfolded Protein Response
2.8K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.8K
T Cell Types and Functions
1.8K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.8K
Pneumonia I: Introduction
551
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
551
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
290
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
290
Pneumonia IV: Management
596
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
596

